In the nearly yearlong battle against the novel coronavirus, hopes of ending the pandemic are riding with the development of COVID-19 vaccines, two of which have already seen emergency approval in the U.S. and have since been rolled out across the country — albeit slowly. 

Many health care workers and residents and staff at long-term care facilities have received either the Pfizer-BioNTech jab, the first to receive emergency approval from the U.S. Food and Drug Administration (FDA), or the one developed by Moderna, the second to be granted such approval from the federal agency. More vaccinations are to follow, with the Trump administration, in an effort to speed the efforts, asking states to widen distribution to include people ages 65 and older, and those at high risk for severe illness by releasing second doses that were being reserved for those who’ve …continued .
[Source: Fox News]